Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABD.L Regulatory News (ABD)

  • There is currently no data for ABD

Research from QuotedData

7 Jun 2022 15:31

RNS Number : 0437O
abrdn New Dawn Invest Trust plc
07 June 2022
 

abrdn New Dawn - Research from QuotedData

 

7th June 2022

 

Over the trough?

 

It has been another tough six months for abrdn New Dawn (ABD) as the Asia Pacific region has had to face new challenges from the Russo-Ukrainian conflict to China's deadliest COVID-19 wave yet (the economic impacts of which have been made worse by Xi Jinping's zero-COVID policy). This has only exacerbated headwinds already in place such as rising inflation. Manager James Thom believes the worst is behind us, but uncertainty and volatility remain. The trust itself has underperformed in the short-term but still boasts strong long-term numbers and, if a new dawn is indeed rising over the region, with India finally enjoying its reformation and the vaccine rollout (mostly) underway, now could be an attractive entry point. The trust is also trading on an 12.4% discount.

 

Full research:

https://quoteddata.com/research/abrdn-new-dawn-over-the-trough-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on abrdn New Dawn Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBUSRUKUNRAR
Date   Source Headline
22nd Sep 202312:59 pmRNSNet Asset Value(s)
21st Sep 202312:30 pmRNSNet Asset Value(s)
20th Sep 202312:41 pmRNSNet Asset Value(s)
19th Sep 202312:59 pmRNSNet Asset Value(s)
18th Sep 20231:21 pmRNSGearing Disclosures
18th Sep 202312:28 pmRNSNet Asset Value(s)
15th Sep 20235:28 pmRNSTransaction in Own Shares
15th Sep 202312:21 pmRNSNet Asset Value(s)
14th Sep 20235:32 pmRNSPortfolio Disclosures
14th Sep 202312:40 pmRNSNet Asset Value(s)
13th Sep 202312:06 pmRNSNet Asset Value(s)
12th Sep 20234:17 pmRNSHolding(s) in Company
12th Sep 202312:28 pmRNSNet Asset Value(s)
11th Sep 20235:22 pmRNSTransaction in Own Shares
11th Sep 20231:19 pmRNSGearing disclosure
11th Sep 202312:42 pmRNSNet Asset Value(s)
8th Sep 202312:44 pmRNSNet Asset Value(s)
7th Sep 202312:15 pmRNSNet Asset Value(s)
7th Sep 202310:01 amRNSMonth End Net Asset Value(s)
5th Sep 20235:17 pmRNSTransaction in Own Shares
5th Sep 202311:31 amRNSNet Asset Value(s)
4th Sep 20231:38 pmRNSGearing Disclosures
4th Sep 202312:41 pmRNSNet Asset Value(s)
1st Sep 20239:45 amRNSTotal Voting Rights
31st Aug 20235:26 pmRNSTransaction in Own Shares
31st Aug 20231:14 pmRNSNet Asset Value(s)
30th Aug 20235:29 pmRNSTransaction in Own Shares
30th Aug 20233:09 pmRNSDoc re. Annual Report
30th Aug 202312:19 pmRNSNet Asset Value(s)
29th Aug 20235:24 pmRNSTransaction in Own Shares
29th Aug 20233:48 pmRNSGearing disclosure
29th Aug 202312:31 pmRNSNet Asset Value(s)
25th Aug 20235:24 pmRNSTransaction in Own Shares
25th Aug 202312:12 pmRNSNet Asset Value(s)
24th Aug 202312:55 pmRNSNet Asset Value(s)
23rd Aug 202312:26 pmRNSNet Asset Value(s)
22nd Aug 202311:42 amRNSNet Asset Value(s)
21st Aug 20231:38 pmRNSGearing disclosure
21st Aug 202312:56 pmRNSNet Asset Value(s)
18th Aug 20231:08 pmRNSNet Asset Value(s)
17th Aug 20231:03 pmRNSNet Asset Value(s)
17th Aug 20237:00 amRNSAnnual Financial Report
16th Aug 202311:30 amRNSNet Asset Value(s)
15th Aug 202311:16 amRNSNet Asset Value(s)
14th Aug 20233:14 pmRNSGearing disclosure
14th Aug 202312:24 pmRNSNet Asset Value(s)
11th Aug 202312:51 pmRNSNet Asset Value(s)
10th Aug 20234:41 pmRNSPortfolio Disclosures
10th Aug 20231:26 pmRNSNet Asset Value(s)
9th Aug 20231:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.